Find Lufenuron manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

78RELATED EXCIPIENT COMPANIES

136EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 103055-07-8, Fluphenacur, Lufenuron, (+)-, Lufenuron, (-)-, 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea, 130841-26-8
Molecular Formula
C17H8Cl2F8N2O3
Molecular Weight
511.1  g/mol
InChI Key
PWPJGUXAGUPAHP-UHFFFAOYSA-N
FDA UNII
9CR45YMS74

Lufenuron
Lufenuron is used in veterinary for the control of flea.
1 2D Structure

Lufenuron

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluorobenzamide
2.1.2 InChI
InChI=1S/C17H8Cl2F8N2O3/c18-6-5-11(32-17(26,27)14(22)16(23,24)25)7(19)4-10(6)28-15(31)29-13(30)12-8(20)2-1-3-9(12)21/h1-5,14H,(H2,28,29,30,31)
2.1.3 InChI Key
PWPJGUXAGUPAHP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C=C2Cl)OC(C(C(F)(F)F)F)(F)F)Cl)F
2.2 Other Identifiers
2.2.1 UNII
9CR45YMS74
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cga 184699

2. Cga-184699

3. Fluphenacur

4. Fluphenacur, Monosodium Salt

5. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylaminocarbonyl)-2,6-difluorobenzamide

2.3.2 Depositor-Supplied Synonyms

1. 103055-07-8

2. Fluphenacur

3. Lufenuron, (+)-

4. Lufenuron, (-)-

5. 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea

6. 130841-26-8

7. Cga-184699

8. Nsc-759097

9. N-((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)carbamoyl)-2,6-difluorobenzamide

10. N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluorobenzamide

11. 9cr45yms74

12. 130841-22-4

13. Chebi:39384

14. N-{[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl}-2,6-difluorobenzamide

15. Benzamide, N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluoro-, (+)-

16. Benzamide, N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluoro-, (-)-

17. Ncgc00095978-02

18. 1r754m4918

19. 4629851k7q

20. Dsstox_cid_14357

21. Dsstox_rid_79146

22. Dsstox_gsid_34357

23. Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro-

24. N-({[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino}carbonyl)-2,6-difluorobenzamide

25. Lufenurone

26. Lufenuronum

27. Cigna

28. Match (pesticide)

29. 3-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-[(2,6-difluorophenyl)carbonyl]urea

30. Lufenuron;(rs)-1-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy) Phenyl]-3-(2,6-difluorobenzoyl) Urea

31. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl)-2,6-difluorobenzamide

32. N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide

33. Program Flavor Tabs

34. Program

35. Cas-103055-07-8

36. Lufenuron [inn:ban]

37. Lufenurone [inn-french]

38. Lufenuronum [inn-latin]

39. Unii-1r754m4918

40. N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide

41. Cga 184699

42. Lufenuron (usp/inn)

43. Lufenuron [inn]

44. Lufenuron [mi]

45. Lufenuron [mart.]

46. Ec 410-690-9

47. Lufenuron [usp-rs]

48. Program [veterinary] (tn)

49. Unii-9cr45yms74

50. Schembl27105

51. Bspbio_002424

52. Mls004712069

53. Spectrum1505355

54. Lufenuron [green Book]

55. Chembl1364906

56. Dtxsid5034357

57. Lufenuron [usp Monograph]

58. Hms3264n09

59. Pharmakon1600-01505355

60. Unii-4629851k7q

61. Sentinel Component Lufenuron

62. Bcp15961

63. Tox21_111542

64. Tox21_300907

65. Mfcd00867616

66. Nsc759097

67. Lufenuron 100 Microg/ml In Methanol

68. Akos022185021

69. Lufenuron Component Of Sentinel

70. Tox21_111542_1

71. Ccg-213976

72. Db11424

73. Nsc 759097

74. N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluoro-benzamide

75. Lufenuron 100 Microg/ml In Acetonitrile

76. Ncgc00095978-01

77. Ncgc00095978-03

78. Ncgc00095978-04

79. Ncgc00095978-06

80. Ncgc00254811-01

81. As-13363

82. Smr001563631

83. Lufenuron 1000 Microg/ml In Acetonitrile

84. Sbi-0207025.p001

85. Db-040412

86. Hy-115584

87. Cs-0088780

88. Ft-0631021

89. L0358

90. Lufenuron, Pestanal(r), Analytical Standard

91. C18434

92. D08150

93. E78989

94. Ab01563233_01

95. Lufenuron (anhydrous) For Veterinary Use

96. 055l078

97. A800670

98. Q412933

99. Sr-01000872762

100. J-521659

101. Sr-01000872762-1

102. Brd-a71774530-001-01-8

103. Brd-a71774530-001-02-6

104. Lufenuron, European Pharmacopoeia (ep) Reference Standard

105. Lufenuron (anhydrous) For Veterinary Use [ep Impurity]

106. Lufenuron, United States Pharmacopeia (usp) Reference Standard

107. Lufenuron For Peak Identification, European Pharmacopoeia (ep) Reference Standard

108. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl)-2,6-difluorobenzamide

109. N-[[2,5-dichloro-4-(1,1,3,4,4,4-hexafluorobutyl)phenyl]carbamoyl]-2,6-difluoro-benzamide

110. (+)-n-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide

111. (-)-n-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide

112. (rs)-1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea

113. 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)-urea

114. Benzamide,n-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro-

2.4 Create Date
2005-08-01
3 Chemical and Physical Properties
Molecular Weight 511.1 g/mol
Molecular Formula C17H8Cl2F8N2O3
XLogP36.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass509.9784228 g/mol
Monoisotopic Mass509.9784228 g/mol
Topological Polar Surface Area67.4 Ų
Heavy Atom Count32
Formal Charge0
Complexity677
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Insecticides

Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725993000,"product":"LUFENURON","address":"3RD FLOOR, NO.301, DOSTI PINNACLE","city":"ESTATE,DIST.THANE WEST, M.S.","supplier":"ALIVIRA ANIMAL HEALTH","supplierCountry":"INDIA","foreign_port":"AUCKLAND","customer":"ARGENTA MANUFACTURING LTD.","customerCountry":"NEW ZEALAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"1000","totalValueFC":"9513.5","currency":"USD","unitRateINR":79724.468999999997,"date":"11-Sep-2024","totalValueINR":"797244.69","totalValueInUsd":"9513.5","indian_port":"Vizag-RPCIPL SEZ","hs_no":"29242990","bill_no":"3928793","productDescription":"API","marketType":"REGULATED MARKET","country":"NEW ZEALAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-RPCIPL SEZ","supplierAddress":"3RD FLOOR, NO.301, DOSTI PINNACLE, ESTATE,DIST.THANE WEST, M.S.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623954600,"product":"LUFENURON (TEST LIC.NO. CT-17\/AZ\/19\/94) FOR R & D PURPOSE NOT FOR SALE","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGARHIGHWAY SATELLITE CROSS ROADS,","city":"AHMEDABAD\/GUJRAT","supplier":"CHEMWERTH INC","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"ZYDUS LIFESCIENCES","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2000","totalValueFC":"6081.9","currency":"USD","unitRateINR":"149100","date":"18-Jun-2021","totalValueINR":"447300","totalValueInUsd":"6081.9","indian_port":"BOMBAY AIR","hs_no":"29329990","bill_no":"4364210","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGARHIGHWAY SATELLITE CROSS ROADS,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638729000,"product":"LUFENURON RELATED COMPOUND C (QTY: 2 X 15 MG, PRICE: USD 838\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"WASHINGTON DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00003","unit":"KGS","unitRateFc":"55866666.7","totalValueFC":"1729.2","currency":"USD","unitRateINR":"4347656333","date":"06-Dec-2021","totalValueINR":"130429.69","totalValueInUsd":"1729.2","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"6545651","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON DULLES I","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638729000,"product":"LUFENURON RELATED COMPOUND G (QTY: 1 X 15 MG, PRICE: USD 838)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"WASHINGTON DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000015","unit":"KGS","unitRateFc":"55866666.7","totalValueFC":"864.6","currency":"USD","unitRateINR":"4347656667","date":"06-Dec-2021","totalValueINR":"65214.85","totalValueInUsd":"864.6","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"6545651","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON DULLES I","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640802600,"product":"LUFENURON RELATED COMPOUND B (QTY: 1 X 15 MG, PRICE: USD 838)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"WASHINGTON DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000015","unit":"KGS","unitRateFc":"55866666.7","totalValueFC":"907.3","currency":"USD","unitRateINR":"4562390000","date":"30-Dec-2021","totalValueINR":"68435.85","totalValueInUsd":"907.3","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"6894792","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON DULLES I","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649615400,"product":"LUFENURON (TEST LIC NO. CT-17\/AZ\/19\/94)","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"CHEMWERTH INC","supplierCountry":"CHINA","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2000","totalValueFC":"20358.1","currency":"USD","unitRateINR":"153600","date":"11-Apr-2022","totalValueINR":"1536000","totalValueInUsd":"20358.1","indian_port":"BOMBAY AIR","hs_no":"29329990","bill_no":"8233458","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660674600,"product":"LUFENURON RELATED COMPOUND B (QTY: 2X15 MG,VALUE: USD 855\/EACH) (FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00003","unit":"KGS","unitRateFc":"57000000","totalValueFC":"1767.5","currency":"USD","unitRateINR":"4687732000","date":"17-Aug-2022","totalValueINR":"140631.96","totalValueInUsd":"1767.5","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"2049200","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660674600,"product":"LUFENURON RELATED COMPOUND G (QTY: 1X15 MG,VALUE: USD 855) (FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000015","unit":"KGS","unitRateFc":"57000000","totalValueFC":"883.7","currency":"USD","unitRateINR":"4687732000","date":"17-Aug-2022","totalValueINR":"70315.98","totalValueInUsd":"883.7","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"2049200","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672597800,"product":"LUFENURON. VOSYLFNN-C066-N. B\/N: V1001220. MFG. DT. 04\/12\/2022 RETEST DT. 03\/12\/2024 (CT-17 NO.: TL\/AZ\/22\/002399 DT. 02\/","address":"SUR. NO. 377\/1B, BS. UDHYAN BUNGLO W,OFF. SG HIGHWAY, ISCON CROSS ROAD","city":"AHMEDABAD,GUJARAT","supplier":"CHEMWERTH INC","supplierCountry":"CHINA","foreign_port":"NA","customer":"XYLOPIA LABS PRIVATE ","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2000","totalValueFC":"10985.4","currency":"USD","unitRateINR":"179632.5","date":"02-Jan-2023","totalValueINR":"898162.5","totalValueInUsd":"10985.4","indian_port":"AHMEDABAD AIR","hs_no":"29242990","bill_no":"4005916","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SUR. NO. 377\/1B, BS. UDHYAN BUNGLO W,OFF. SG HIGHWAY, ISCON CROSS ROAD"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672597800,"product":"LUFENURON. VOSYLFNN-C066-N. B\/N: V1001220. MFG. DT. 04\/12\/2022 RETEST DT. 03\/12\/2024 (CT-17 NO.: TL\/AZ\/22\/002399 DT. 02\/","address":"SUR. NO. 377\/1B, BS. UDHYAN BUNGLO W,OFF. SG HIGHWAY, ISCON CROSS ROAD","city":"AHMEDABAD,GUJARAT","supplier":"CHEMWERTH INC","supplierCountry":"CHINA","foreign_port":"NA","customer":"XYLOPIA LABS PRIVATE ","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2000","totalValueFC":"21204.4","currency":"USD","unitRateINR":"173366.3","date":"02-Jan-2023","totalValueINR":"1733662.5","totalValueInUsd":"21204.4","indian_port":"AHMEDABAD AIR","hs_no":"29242990","bill_no":"4005917","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SUR. NO. 377\/1B, BS. UDHYAN BUNGLO W,OFF. SG HIGHWAY, ISCON CROSS ROAD"}]
18-Jun-2021
11-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Lubricants & Glidants

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 130841-22-4 / Lufenuron API manufacturers, exporters & distributors?

Lufenuron manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Lufenuron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lufenuron manufacturer or Lufenuron supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lufenuron manufacturer or Lufenuron supplier.

PharmaCompass also assists you with knowing the Lufenuron API Price utilized in the formulation of products. Lufenuron API Price is not always fixed or binding as the Lufenuron Price is obtained through a variety of data sources. The Lufenuron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Lufenuron

Synonyms

103055-07-8, Fluphenacur, Lufenuron, (+)-, Lufenuron, (-)-, 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea, 130841-26-8

Cas Number

130841-22-4

Unique Ingredient Identifier (UNII)

9CR45YMS74

About Lufenuron

Lufenuron is used in veterinary for the control of flea.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard Manufacturers

A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard, including repackagers and relabelers. The FDA regulates Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard Suppliers

A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard supplier is an individual or a company that provides Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard active pharmaceutical ingredient (API) or Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard finished formulations upon request. The Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers may include Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API manufacturers, exporters, distributors and traders.

click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP

A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP of the European Pharmacopoeia monograph is often referred to as a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard Certificate of Suitability (COS). The purpose of a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard to their clients by showing that a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP has been issued for it. The manufacturer submits a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP holder for the record. Additionally, the data presented in the Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard DMF.

A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers with CEP (COS) on PharmaCompass.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers with NDC on PharmaCompass.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard GMP

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard GMP manufacturer or Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard GMP API supplier for your needs.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CoA

A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CoA (Certificate of Analysis) is a formal document that attests to Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard's compliance with Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard specifications and serves as a tool for batch-level quality control.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CoA mostly includes findings from lab analyses of a specific batch. For each Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard may be tested according to a variety of international standards, such as European Pharmacopoeia (Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard EP), Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty